(Total Views: 247)
Posted On: 07/20/2017 2:22:18 PM
Post# of 72440
What a bunch of BS from noretreat. If IPIX had only one drug, and it failed, that disaster scenario might be true. But IPIX has Brilacidin-UP and Brilacidin-OM that have been very successful thus far -- hard to think of what could stop these drugs from progressing to approval -- and also Kevetrin has had good results so far.
Even JUST Bril-UP or Bril-OM would warrant a much higher share price than we have now. One would have to know NOTHING about this company to think that it is priced fairly now. I think it should be at a minimum of 5.
And if Prurisol works well, great, an added bonus that certainly is not being factored into the share price now.
These bashers are sociopaths, like Shkreli in the article that a couple of us posted this morning. And what's worse is the bashers who turn to pumping, and then won't STFU even though everyone knows what their other main screen name is.
Even JUST Bril-UP or Bril-OM would warrant a much higher share price than we have now. One would have to know NOTHING about this company to think that it is priced fairly now. I think it should be at a minimum of 5.
And if Prurisol works well, great, an added bonus that certainly is not being factored into the share price now.
These bashers are sociopaths, like Shkreli in the article that a couple of us posted this morning. And what's worse is the bashers who turn to pumping, and then won't STFU even though everyone knows what their other main screen name is.
(5)
(0)Scroll down for more posts ▼
